Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EnteroMedics Inc    ETRM

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2017 1,51 M
EBIT 2017 -25,1 M
Net income 2017 -
Debt 2017 -
Yield 2017 -
Sales 2018 -
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018 -
Capi. / Sales2017 11,2x
Capi. / Sales2018 -
Capitalization 16,8 M
More Financials
Company
EnteroMedics, Inc. is a clinical development stage medical device company that engages in the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.Its proprietary neuroblocking technology is designed to... 
Sector
Advanced Medical Equipment & Technology
Calendar
09/26 | 05:00pmPresentation
More about the company
Latest news on ENTEROMEDICS INC
08/31 ENTEROMEDICS : Announces First Veterans Choice Program vBloc® Implant at MedStar..
08/16 ENTEROMEDICS INC : Entry into a Material Definitive Agreement, Material Modifica..
08/16 ENTEROMEDICS : Announces Presentations Highlighting vBloc and Gastric Vest at IF..
08/11 ENTEROMEDICS : Announces Pricing of $20 Million Underwritten Public Offering
08/11 ENTEROMEDICS INC. (NASDAQ : ETRM) Files An 8-K Regulation FD Disclosure
08/11 ENTEROMEDICS INC : Regulation FD Disclosure (form 8-K)
08/10 ENTEROMEDICS : Announces Proposed Underwritten Public Offering
08/08 ENTEROMEDICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
08/08 ENTEROMEDICS INC. (NASDAQ : ETRM) Files An 8-K Results of Operations and Financi..
08/08 ENTEROMEDICS INC : Results of Operations and Financial Condition, Financial Stat..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
08/31DJROYAL PHILIPS : Prices Offering of Notes for EUR1.0 Billion
08/03DJHot Stocks to Watch in the U.S. and Canada
07/24 Autos, airlines hit in sluggish start to European trading week
07/24 ROYAL PHILIPS : Philips targets order book growth of 4-6 percent in 2017 - CEO
07/24DJROYAL PHILIPS : 2Q Net Profit Rises; Begins EUR1.5 Billion Share Buyback Program
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
2016 Medtech Approvals Of The Strange Kind
2015 EnteroMedics Will Do 1 For 15 Reverse Split - This Is Not A Good Way To Start..
2015 ENTEROMEDICS TO REVERSE SPLIT SHARES : 15
2015 EnteroMedics' (ETRM) CEO Dan Gladney on Q3 2015 Results - Earnings Call Trans..
2015 EnteroMedics - Investors Need To Have Realistic Expectations
Chart ENTEROMEDICS INC
Duration : Period :
EnteroMedics Inc Technical Analysis Chart | ETRM | US29365M2089 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus BUY
Number of Analysts 1
Average target price 7,50 $
Spread / Average Target 269%
Managers
NameTitle
Dan W. Gladney Chairman, President & Chief Executive Officer
Peter M. Delange Senior VP-Operations & Business Development
Scott P. Youngstrom Chief Financial & Compliance Officer, Secretary
Raj Nihalani Chief Technology Officer
Carl Samuel Goldfischer Independent Class I Director
Sector and Competitors
1st jan.Capitalization (M$)
ENTEROMEDICS INC53.73%17
THERMO FISHER SCIENTIFIC INC.33.45%75 111
DANAHER11.49%60 285
BOSTON SCIENTIFIC CORPORATION32.96%39 586
ROYAL PHILIPS20.86%39 413
INTUITIVE SURGICAL62.66%38 322